{"entity":{"id":"nct02234297","kind":"trial","name":"Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery","aka":[],"tldr":"A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., completed.","summary":"Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery is a phase 1 interventional study registered as NCT02234297 by Blaze Bioscience Inc., with 17 participants enrolled, started 2014-10. Conditions recorded: Glioma. Interventions recorded: BLZ-100.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT02234297","url":"https://clinicaltrials.gov/study/NCT02234297"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["brain-tumours"],"sections":[],"technologies":[],"targets":[],"drugs":["blz-100"],"companies":["blaze-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02234297","phase":"1","setting":"A Phase 1 Dose Escalation/Expansion Study of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Glioma Undergoing Surgery","sponsor":"Blaze Bioscience Inc.","enrolled":17,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02234297/","neighbours":{"cancer":[{"id":"brain-tumours","kind":"cancer","name":"Brain and spinal cord tumours (all types)","route":"/cancers/brain-tumours/"}],"drug":[{"id":"blz-100","kind":"drug","name":"Tozuleristide","route":"/drugs/blz-100/"}],"company":[{"id":"blaze-bioscience","kind":"company","name":"Blaze Bioscience","route":"/companies/blaze-bioscience/"}]}}